Tracers / [18F]AlF

[18F]AlF

Also written as [18F]AlF; [18F]AlF2+; [F-18]AlF; [F-18]AlF2+; AlF; F-18 AlF
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
Stage
Syntheses indexed
1

What it is

Compound class
RGD peptide, NOTA-conjugated (NOTA-PRGD2), labeled via Al18F
Target / mechanism
Integrin αvβ3 PMID 23554506
Clinical application
PET imaging of integrin αvβ3 expression in lung cancer patients for angiogenesis assessment PMID 23554506
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
custom manifoldSPE42.1% ± 2.0%
yes
more than 95%NOTA-PRGD223554506
2013 J Nucl Med

Need this precursor?We can point you to suppliers for [18F]AlF, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]AlF.

Get in touch

Notes

Added from reverse module search (stage 6); 22 article(s) with F-18. Compound class inferred from precursor name (not stated outright) -- PMID 23554506: 'NOTA-PRGD2'.